Post-chemotherapy cognitive impairment medical therapy: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Post-chemotherapy cognitive impairment}} {{PleaseHelp}} ==References== {{Reflist|2}}")
 
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Post-chemotherapy cognitive impairment}}
{{Post-chemotherapy cognitive impairment}}
{{PleaseHelp}}
 
{{CMG}}
 
==Treatment==
Hypothesized treatment options include the use of [[antioxidant]]s, [[cognitive behavior therapy]], [[erythropoietin]] and stimulant drugs such as [[methylphenidate]], though as the mechanism of PCCI is not well understood the potential treatment options are equally theoretical.
 
[[Modafinil]], approved for [[narcolepsy]], has been used [[off-label]] in trials with people with symptoms of PCCI. Modafinil is a wakefulness-promoting agent that can improve alertness and concentration, and studies have shown it to be effective at least among women treated for breast cancer.<ref>[http://content.hamptonroads.com/story.cfm?story=133730&ran=181335 Doctors are finding it harder to deny "Chemobrain"] The Virginian-Pilot October 2, 2007</ref><ref>[http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=111136  Modafinil Relieves Cognitive Chemotherapy Side Effects]  Psychiatric News, Stephanie Whyche, August 3, 2007 Volume 42 Number 15, page 31</ref>
 
While estrogen hormone supplementation may reverse the symptoms of PCCI in women treated for breast cancer, this carries health risks, including possibly promoting the proliferation of estrogen-responsive breast cancer cells.


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 16:04, 18 August 2015

Post-chemotherapy cognitive impairment Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Post-chemotherapy cognitive impairment from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Post-chemotherapy cognitive impairment medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Post-chemotherapy cognitive impairment medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Post-chemotherapy cognitive impairment medical therapy

CDC on Post-chemotherapy cognitive impairment medical therapy

Post-chemotherapy cognitive impairment medical therapy in the news

Blogs on Post-chemotherapy cognitive impairment medical therapy

Directions to Hospitals Treating Post-chemotherapy cognitive impairment

Risk calculators and risk factors for Post-chemotherapy cognitive impairment medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Treatment

Hypothesized treatment options include the use of antioxidants, cognitive behavior therapy, erythropoietin and stimulant drugs such as methylphenidate, though as the mechanism of PCCI is not well understood the potential treatment options are equally theoretical.

Modafinil, approved for narcolepsy, has been used off-label in trials with people with symptoms of PCCI. Modafinil is a wakefulness-promoting agent that can improve alertness and concentration, and studies have shown it to be effective at least among women treated for breast cancer.[1][2]

While estrogen hormone supplementation may reverse the symptoms of PCCI in women treated for breast cancer, this carries health risks, including possibly promoting the proliferation of estrogen-responsive breast cancer cells.

References

  1. Doctors are finding it harder to deny "Chemobrain" The Virginian-Pilot October 2, 2007
  2. Modafinil Relieves Cognitive Chemotherapy Side Effects Psychiatric News, Stephanie Whyche, August 3, 2007 Volume 42 Number 15, page 31